Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOSTARLIMAB for Cervix neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 51 adverse event reports in the FDA FAERS database where DOSTARLIMAB was used for Cervix neoplasm.

Most Reported Side Effects for DOSTARLIMAB

Side Effect Reports % Deaths Hosp.
Malignant neoplasm progression 111 12.4% 38 17
Thrombocytopenia 42 4.7% 0 17
Fatigue 38 4.3% 1 12
Anaemia 36 4.0% 9 17
Death 31 3.5% 31 3
Arthralgia 30 3.4% 1 9
Diarrhoea 29 3.3% 3 14
Rash 29 3.3% 0 14
Condition aggravated 27 3.0% 7 14
Dyspnoea 26 2.9% 2 20
Nausea 26 2.9% 6 13
Neuropathy peripheral 26 2.9% 2 4
Abdominal pain 25 2.8% 3 20
Off label use 24 2.7% 3 7
Pyrexia 24 2.7% 2 16

Other Indications for DOSTARLIMAB

Endometrial cancer (315) Ovarian cancer (119) Endometrial cancer recurrent (115) Neoplasm (106) Non-small cell lung cancer (51) Product used for unknown indication (39) Endometrial neoplasm (29) Breast cancer (25) Endometrial adenocarcinoma (25) Endometrial cancer metastatic (16)

Other Drugs Used for Cervix neoplasm

CARBOPLATIN (63) PACLITAXEL (59) CISPLATIN (6)

Related Pages

DOSTARLIMAB Full Profile All Cervix neoplasm Drugs DOSTARLIMAB Demographics DOSTARLIMAB Timeline